Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
Publication date
2021-01-25
Authors
Vogler, Sabine
Zimmermann, Nina
Babar, Zaheer Ud Din
Busse, Reinhard
Espin, Jaime
Mantel-Teeuwisse, Aukje K
Panteli, Dimitra
Suleman, F.
Wirtz, Veronika J.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by
Abstract
The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.
Keywords
Access to medicines, Affordability, Collaboration, Debate, Medicine prices, Policy options, Pricing policies, Reimbursement, Pharmacology, Toxicology and Pharmaceutics(all), Health Policy, SDG 3 - Good Health and Well-being
Citation
Vogler, S, Zimmermann, N, Babar, Z U D, Busse, R, Espin, J, Mantel-Teeuwisse, A K, Panteli, D, Suleman, F & Wirtz, V J 2021, 'Addressing the medicines access challenge through balance, evidence, collaboration and transparency : key take-away lessons of the 4th PPRI Conference', Journal of Pharmaceutical Policy and Practice, vol. 14, no. 1, 18, pp. 1-5. https://doi.org/10.1186/s40545-021-00300-3